Printer Friendly
The Free Library
14,709,470 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Amgen's Psoriasis spots, latest target in FDA crackdown on ads, get pulled.


Should Amgen Inc. have known better? That's a fair question following the Food and Drug Administration's demand that the Thousand Oaks-based biotech company pull a television ad for its psoriasis psoriasis (sôrī`əsĭs), occasionally acute but usually chronic and recurrent inflammation of the skin. The exact cause is unknown, but the disease appears to be an inherited, possibly autoimmune disorder that causes the  drug Enbrel.

The FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 has been questioning the safety of numerous prescription drugs being marketed on television. In a letter to Amgen, the agency contended that the ads overstated o·ver·state  
tr.v. o·ver·stat·ed, o·ver·stat·ing, o·ver·states
To state in exaggerated terms. See Synonyms at exaggerate.



o
 Enbrel's effectiveness while minimizing the risks.

The ad featured minimally dressed adults without any of the red lesions that are notable signs of psoriasis--giving the impression that the drug is 100 percent effective, even though no studies show that.

Moreover, according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 the FDA, the ad failed to convey that the drug has potentially serious side effects Side effects

Effects of a proposed project on other parts of the firm.
, including raising the risk of tuberculosis and the cancer lymphoma.

"They were showing patients on TV going to the beach with their shirt off who looked like they never had psoriasis," said Adam Walsh, a Jefferies & Co. analyst. "Sometimes the marketing departments at pharmaceutical companies push the envelope."

Amgen spokeswoman Nurha Hindi declined to discuss the matter in detail. "We are really digging into the letter and talking to Noun 1. talking to - a lengthy rebuke; "a good lecture was my father's idea of discipline"; "the teacher gave him a talking to"
lecture, speech

rebuke, reprehension, reprimand, reproof, reproval - an act or expression of criticism and censure; "he had to
 FDA to understand their concern and act accordingly," she said.

Lately the FDA has gone after prescription pain relievers Vioxx, Celebrex and others over safety concerns. Merck & Co.'s Vioxx was advertised as a safe arthritis drug, only to be later linked to more than 25,000 cardiovascular deaths. Vioxx was pulled from the market voluntarily.

This month, an FDA panel strongly recommended against allowing direct-to-consumer advertising direct-to-consumer advertising Drug industry The use of mass media–eg, TV, magazines, newspapers, to publicly promote drugs, medical devices or other products which, by law, require a prescription, which targets consumers, with the intent of having a Pt  if Vioxx is allowed back on the market.

Pfizer Inc.'s Celebrex is still on the market, but the FDA ordered the company to withdraw its ads, saying they overstated benefits and minimized risks.

Last November, the agency ordered Pfizer to pull two television ads for Viagra, also noting they overstated that drug's effectiveness also while minimizing its risk.
COPYRIGHT 2005 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Media & Technology
Comment:Amgen's Psoriasis spots, latest target in FDA crackdown on ads, get pulled.(Media & Technology)
Author:Darmiento, Laurence
Publication:Los Angeles Business Journal
Geographic Code:1USA
Date:Feb 28, 2005
Words:311
Previous Article:Boingo partners with Boeing for Airborne WiFi.(Media & Technology)
Next Article:Mediawatch.
Topics:



Related Articles
AMGEN GETS DRUG OK ARTHRITIS PRODUCT EXPANDS COMPANY'S MARKET REACH.(Business)
AMGEN OUTDOES EXPECTATIONS ON TWO FRONTS.(News)
AMGEN DRUG FOUND EFFECTIVE FOR PSORIASIS ENBREL TRIALS TO FINISH IN '03.(Business)
AMGEN POSTS BIG 4TH QUARTER SALES LEAD TO TRIPLING IN PROFITS.(Business)(Statistical Data Included)
Stock buyback, patent victory give bounce to Amgen shares.(Corporate Focus)
AMGEN TINY FIRM BECAME WORLD BIOTECH LEADER.(News)
Amgen to allow FDA review of advertising for its products.(INVESTMENTS & FINANCE)
Amgen finds it's a new world after Vioxx deaths and verdict.(DRUGMAKERS UNDER FIRE)
Amgen shows some signs of slipping off the cutting edge.
Amgen INC. (AMGN).(WEEKLY PROFILE)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles